Medicare Enrolled

Dr. Michael Marmura, MD

Neurology · Philadelphia, PA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
900 WALNUT ST, Philadelphia, PA 19107
2159552243
In practice since 2007 (19 years)
NPI: 1326257734 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marmura from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marmura? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marmura

Dr. Michael Marmura is a neurology specialist in Philadelphia, PA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Marmura performed 328 Medicare services across 211 unique beneficiaries.

Between the years covered by Open Payments, Dr. Marmura received a total of $233,797 from 38 pharmaceutical and/or device companies across 898 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marmura is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 49% volume in PA $233,797 industry payments

Medicare Practice Summary

Medicare Utilization ↗
328
Medicare services
Top 49% in PA for neurology
211
Unique beneficiaries
$84
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~17 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Bilateral facial and neck nerve muscle paralysis injection
Injection of a chemical agent to paralyze muscles in the face and neck on both sides.
115 $98 $435
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
85 $66 $130
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
58 $68 $275
New patient office visit, complex (60-74 min) 27 $131 $425
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $44 $190
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
17 $109 $245
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$233,797
Total received (2018-2024)
Avg $33,400/year across 7 years
Top 5% in PA for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
38
Companies
898
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$213,765 (91.4%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$10,716 (4.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,316 (4.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,812
2023
$24,213
2022
$25,355
2021
$27,849
2020
$61,897
2019
$55,900
2018
$33,770

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$2,906
Lilly USA, LLC
$1,040
PFIZER INC.
$342
Lundbeck LLC
$211
Teva Pharmaceuticals USA, Inc.
$156
Amgen Inc.
$46
Ipsen Biopharmaceuticals, Inc
$35
Tonix Medicines, Inc.
$29
Axsome Therapeutics, Inc.
$26
SCILEX PHARMACEUTICALS INC.
$22
Top 3 companies account for 89.1% of 2024 payments
All-time payments by company (2018-2024) ›
Lilly USA, LLC
$142,369
Amgen Inc.
$32,296
Lundbeck LLC
$23,830
H. Lundbeck A S
$11,313
Supernus Pharmaceuticals, Inc.
$5,034
ABBVIE INC.
$4,437
Bausch Health US, LLC
$4,363
Teva Pharmaceuticals USA, Inc.
$2,562
UPSHER-SMITH LABORATORIES LLC
$2,211
Biogen, Inc.
$900
PFIZER INC.
$791
Allergan Inc.
$744
IMPEL PHARMACEUTICALS INC.
$480
Novartis Pharmaceuticals Corporation
$432
Biohaven Pharmaceutical Holding Company Ltd.
$424
Promius Pharma LLC
$278
Allergan, Inc.
$277
Biohaven Pharmaceuticals, Inc.
$134
Amneal Pharmaceuticals LLC
$129
Avanir Pharmaceuticals, Inc.
$113
Upsher-Smith Laboratories LLC
$98
Ipsen Biopharmaceuticals, Inc
$62
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$59
ASSERTIO THERAPEUTICS, Inc.
$58
Assertio Therapeutics, Inc.
$47
AbbVie Inc.
$46
Collegium Pharmaceutical, Inc.
$45
IDORSIA PHARMACEUTICALS US INC
$41
TerSera Therapeutics LLC
$31
Electronic Waveform Lab, Inc.
$29
Tonix Medicines, Inc.
$29
Impax Laboratories, Inc.
$29
Axsome Therapeutics, Inc.
$26
SCILEX PHARMACEUTICALS INC.
$22
Scilex Pharmaceuticals Inc.
$18
Zyla Life Sciences, Inc.
$16
Vertical Pharmaceuticals, LLC
$13
Zyla Life Sciences
$13
Top 3 companies account for 84.9% of all-time payments
Associated products mentioned in payments ›
AIMOVIG · AJOVY · AMYVID · AUSTEDO · Aimovig · Austedo XR · BOTOX · BOTOX - NEUROLOGY · BOTOX THERAPEUTIC · COMIRNATY · Cambia · DYSPORT · Dysport · ELYXYB - celecoxib · EMGALITY · ERGOMAR · MIGRANAL · NUEDEXTA · NURTEC ODT · OSMOLEX ER · PAXLOVID · QUDEXY XR Topiramate Extended Release Capsules · QULIPTA · QUVIVIQ · RELISTOR · REYVOW · SPRIX · TOPIRAMATE Extended Release Capsules · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TROKENDI XR · Trudhesa · UBRELVY · VRAYLAR · VYEPTI · ZEMBRACE SYMTOUCH · ZOMIG · ZTLido · Zembrace
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (91%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in neurology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 5% for neurology in PA.

Looking for a neurology specialist in Philadelphia?
Compare neurologists in the Philadelphia area by procedure volume, costs, and industry payment transparency.
Browse neurologists nearby

Geographic Context

Neurologists within 10 mi
516
Per 100K population
32.6
County median income
$60,698
Nearest hospital
THOMAS JEFFERSON UNIVERSITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Marmura is a clinical cardiology specialist, with moderate Medicare volume, with speaking/promotional industry engagement in the top 5% of PA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Marmura experienced with bilateral facial and neck nerve muscle paralysis injection?
Based on Medicare claims data, Dr. Marmura performed 115 bilateral facial and neck nerve muscle paralysis injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marmura receive payments from pharmaceutical companies?
Yes. Dr. Marmura received a total of $233,797 from 38 companies across 898 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marmura's costs compare to other neurologists in Philadelphia?
Dr. Marmura's average Medicare payment per service is $84. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marmura) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →